The government announced today (15th) that it will secure 30 million corona vaccines overseas that can be vaccinated by 60% of the people.
In the future, we are planning to secure additional vaccinations aimed at all national vaccinations.
Currently, the only vaccine candidate in the phase 3 clinical trial stage in which a Korean company participated is being developed jointly by AstraZeneca, a multinational pharmaceutical company, with Oxford University in the UK.
It is the product that temporarily suspended the phase 3 clinical trial due to the recent occurrence of side effects and then resumed it.
In July, the Ministry of Health and Welfare signed a letter of intent with SK Bioscience, a domestic company, to cooperate with AstraZeneca in securing vaccine candidates.
However, it has not been determined when AstraZeneca's vaccine candidates will be commercialized or how much will be available.
In response, the government plans to secure about 10 million vaccines through participation in'CoVax Facility' and about 20 million through negotiations with leading overseas companies.
You can participate by joining the World Vaccine Immunity Alliance GAVI, which is responsible for supplying vaccines around the world.
The government has already submitted a confirmation of intent to join last month.
In addition, Im In-taek, director of health industry policy at the Ministry of Health and Welfare, said at a briefing today, "We are in consultation with overseas pharmaceutical companies such as NovaVax, Piza, Johnson & Johnson, and Modena in addition to AstraZeneca."
Director Lim added, "AstraZeneca has expressed its intention to donate vaccines for at least 10 million people to the Korean government, and NovaVax is also being produced in Korea, so we will be able to secure supplies."
Lim predicted that "if it is judged that the secured vaccine is not dangerous, the Korea Centers for Disease Control and Prevention will be able to establish an implementation plan for vaccination by October this year."
This is'News Pick'.